Edrophonium achieved 83.5% sensitivity and 87.7% specificity across 182 myasthenia gravis cases and 324 controls. Test positivity remained similar across postsynaptic acetylcholine receptor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results